The use of tyrosine kinase inhibitors (TKIs) to treat the 10–20% of lung adenocarcinomas with mutations in the EGFR gene is a recent success story in cancer medicine, but many tumors develop drug resistance after an initial response. Developing effective second-line therapy requires knowledge of the molecular basis of resistance, which is still unknown in many cases. Here, Katerina Politi and colleagues describe a mouse model of EGFR-induced lung tumors that, when treated with the TKI inhibitor erlotinib, become drug-resistant. This model will allow the mutations that cause resistance to be quickly identified and can also be used as a preclinical system to evaluate new therapeutic strategies. This research report is freely accessible online.
Drug-resistant lung cancers modeled in mice
Drug-resistant lung cancers modeled in mice. Dis Model Mech 14 January 2010; 3 (1-2): 1. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2023: Infectious Diseases Through an Evolutionary Lens

The abstract submission deadline for our 2023 Journal Meeting ‘Infectious Diseases Through an Evolutionary Lens’ is 14 July 2023. Find out more and register here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Propose a new Workshop for 2025

Do you have an idea for a Workshop? If so, click here. We are now accepting proposals for our 2025 Workshops programme. As the scientific organiser, your involvement will be focused on the science. We'll take care of all the logistics. In 2025 we'll continue our efforts to diversify our Workshop programme and will be reserving one of our Workshops for an application from a Global South country to host an event overseas.
How stromal cells restrict liver cancer invasion

In our recent editor’s choice, Liqin Zhu and colleagues describe how they used in vitro liver spheroid models consisting of both parenchymal and non-parenchymal cells to reveal a hepatoprotective role for peritumoral hepatic stellate cells in liver tumorigenesis.
And from perspective… Hacking haematopoiesis – emerging tools for examining variant effects

Thousands of genomic loci have been linked to hematopoietic traits and diseases, yet many await functional validation. Michael Gundry and Vijay G. Sankaran discuss recent advances in genome editing and the challenges associated with using these techniques to assess variant function in primary hematopoietic cells.
Other journals from
The Company of Biologists